CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol.18, no.7, pp.1609-1621, 2020 (SCI-Expanded)
BACKGROUND & AIMS: Changes in serum levels of transaminases immediately after initiation of treatment for autoimmune hepatitis (AIH) might be associated with biochemical markers of remission and liver-related events. We assessed the outcomes of patients with vs without rapid response to treatment of AIH in a large international cohort.